Hospital costs for treatment of acute heart failure: Economic analysis of the REVIVE II study

Business & Economics

• Heart Failure 100%
• Hospital Costs 73%
• Admission 56%
• Efficacy 56%
• Economic Analysis 54%
• Evaluation 32%
• Emergency Department 20%
• Length of Stay 18%
• Median 14%
• Drug Treatment 11%
• Costs 11%
• Case Report 11%
• Blood Pressure 10%
• Intensive Care Unit 10%
• Cost-effectiveness 10%
• Randomization 9%
• Inpatients 8%
• Labeling 8%
• Cost Function 7%
• Cost Savings 6%
• Inclusion 6%
• Econometrics 6%
• United States of America 3%

Medicine & Life Sciences

• Simendan 90%
• Hospital Costs 68%
• Economics 46%
• Heart Failure 44%
• Standard of Care 21%
• Costs and Cost Analysis 16%
• Therapeutics 9%
• Hospital Emergency Service 6%
• Length of Stay 5%
• Hospital Records 4%
• Hospital Departments 4%
• Diuretics 3%
• Random Allocation 3%
• Hypotension 3%
• Cost-Benefit Analysis 3%
• Intensive Care Units 3%
• Inpatients 3%
• Placebos 2%
• Survival 2%
• Pharmaceutical Preparations 1%

Social Sciences

• costs 33%
• hospital admission 28%
• evaluation 27%
• economics 25%
• hospital treatment 10%
• Drug Administration 9%
• blood pressure 8%
• econometrics 7%
• inclusion 4%
• Group 4%
• cause 3%